According to Nevro 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.975757. At the end of 2023 the company had a P/S ratio of 1.83.
Year | P/S ratio | Change |
---|---|---|
2023 | 1.83 | -46.92% |
2022 | 3.45 | -52.79% |
2021 | 7.31 | -55.57% |
2020 | 16.5 | 73.26% |
2019 | 9.50 | 212.63% |
2018 | 3.04 | -51.47% |
2017 | 6.26 | -31.54% |
2016 | 9.15 | -66.49% |
2015 | 27.3 | -7.53% |
2014 | 29.5 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Thermo Fisher Scientific TMO | 5.11 | 423.57% | ๐บ๐ธ USA |
Abiomed ABMD | 16.0 | 1,539.29% | ๐บ๐ธ USA |
Intuitive Surgical ISRG | 18.7 | 1,815.01% | ๐บ๐ธ USA |
Orthofix Medical
OFIX | 0.6513 | -33.25% | ๐บ๐ธ USA |